- Highlights the lessons learned from the journey behind discovery science, which are applicable to the scientific journey of the next generation of scientists
- Provides a manual on the successful mentoring of young scientists to become leaders in academia and the pharmaceutical industry
- Examines cancer treatment based on a personal determination to challenge at the frontiers of the science and to relate to personal life experience
- Includes references for further research reading
1. Leeds University: foundation of a career 2. The chance to be a PhD student at Leeds University 3. A new strategy: long-term adjuvant tamoxifen therapy first proposed at Leeds University 4. Two opportunities! 5. Academic advancement 6. Two new challenges in cancer centers 7. Four decades of discovery 8. Sliding door and serendipity 9. Closing the circle on tamoxifen tales 10. Reborn in Texas 11. Case studies: in their own words 12. Scientific survival suggestions 13. Appendices
V. Craig Jordan is Professor of Breast Medical Oncology, Professor of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Previously, he was Scientific Director and Vice Chairman of Oncology at the Lombardi Comprehensive Cancer Center of Georgetown University. Jordan was the first to discover the breast cancer prevention properties of tamoxifen and the scientific principles for adjuvant therapy with antihormones. More recently his work has branched out into the prevention of multiple diseases in women with the discovery of the drug group, selective estrogen receptor modulator (SERMs). Currently, he plans to develop a new Hormone Replacement Therapy (HRT) for post-menopausal women that prevents breast cancer and does not increase the risk of breast cancer. In 2019 he was appointed Companion of the Most Distinguished Order of St. Michael and St. George by Queen Elizabeth II for services to women's health.